Clinical Trial Update: Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cisplatin with or without pemetrexed disodium in patients with unresectable malignant pleural mesothelioma. The study status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• CISPLATIN (cisplatin)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Malignant Mesothelioma | Phase 3 | Status: COMPLETED